Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medigen Vaccine Biologics Corp. (6547) Income Statement

Medigen Vaccine Biologics Corp. Income Statement

Last quarter (Q2 2026), Medigen Vaccine Biologics Corp.'s total revenue was NT$115.05M, a decrease of 20.59% from the same quarter last year. In Q2, Medigen Vaccine Biologics Corp.'s net income was NT$22.35M. See Medigen Vaccine Biologics Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 613.17MNT$ 605.64MNT$ 389.62MNT$ 365.04MNT$ 3.28B
NT$ 364.67MNT$ 396.42MNT$ 230.22MNT$ -212.60MNT$ 2.31B
NT$ 630.37MNT$ 542.09MNT$ 1.44BNT$ 1.32BNT$ 1.34B
Depreciation and AmortizationNT$ 141.79MNT$ 136.44MNT$ 131.17MNT$ 127.89MNT$ 112.54M
NT$ -123.90MNT$ 74.86MNT$ -991.09MNT$ -1.32BNT$ 1.53B
NT$ -265.69MNT$ -145.67MNT$ -1.21BNT$ -1.45BNT$ 1.42B
NT$ -16.02MNT$ 65.20MNT$ 53.99MNT$ 61.69MNT$ 446.52M
NT$ -281.71MNT$ -80.47MNT$ -1.16BNT$ -1.47BNT$ 1.41B
NT$ -281.71MNT$ -80.47MNT$ -1.16BNT$ -1.50BNT$ 1.41B
Per Share Metrics
Basic EPSNT$ -0.86NT$ -0.24NT$ -3.53NT$ -4.64NT$ 4.47
Diluted EPSNT$ -0.86NT$ -0.24NT$ -3.53NT$ -4.64NT$ 4.42
Weighted Average Shares Outstanding327.57M328.63M328.31M323.48M315.53M
Weighted Average Shares Outstanding (Diluted)327.57M328.66M328.31M323.48M319.11M

Currency in TWD

Medigen Vaccine Biologics Corp. Earnings and Revenue History

-2B02B4B-60000 %-30000 %0 %30000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin